—Mkt Cap: —P/E: —
Femasys Inc., a biomedical company, develops and commercializes therapeutic and diagnostic products for women's reproductive health needs in the United States and internationally. The company offers FemaSeed, an intratub…
Industry Peers
Health Care Technologyloading…
Indicators:|
Key Statistics
Company
Market Cap—
Enterprise Value21.39M USD
Revenue (TTM)2.29M USD
Gross Profit1.42M USD
Net Income (TTM)-18.63M USD
Revenue/Share0.0580 USD
Last Price—
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees51
CountryUS
SectorHealth Care
IndustryHealth Care Technology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.16
PEG—
EV/EBITDA-1.24
EV/Revenue9.33
P/S8.88
P/B3.44
EPS (TTM)-0.24
EPS (Forward)-0.29
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin61.96%
Oper. Margin-568.33%
EBITDA Margin0.00%
Profit Margin-812.27%
ROE-317.38%
ROA-89.88%
Growth
Revenue Growth39.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-18.69M USD
CapEx (TTM)630.10K USD
FCF Margin-519.19%
FCF Yield—
Net Debt-4.57M USD
Net Debt/EBITDA0.26
Balance Sheet
Debt/Equity0.80
Current Ratio4.53
Quick Ratio2.79
Book Value/Sh0.0980 USD
Cash/Share0.1530 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.7 (Buy)
Target (Mean)8.750 USD
Target Range3.000 USD – 12.00 USD
# Analysts4
Ownership
Shares Out.60.39M
Float49.93M
Insiders9.28%
Institutions10.23%
Short Interest
Short Ratio3.2d
Short % Float3.34%
Short % Out.3.20%
Shares Short1.93M
Short (prev mo.)1.99M
Technical
SMA 500.4342 USD
SMA 2000.5797 USD
Beta-2.25
S&P 52W Chg28.31%
Avg Vol (30d)—
Avg Vol (10d)532.72K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—